Poor diet worsens the symptoms of fibromyalgia, possibly as a result of impaired glycolysis and carbohydrate metabolism. Tobacco use should cease, as should the consumption of chemical-laden foods, refined sugars, white flour, aspartame, and monosodium glutamate (MSG). A diet high in fresh vegetables, fish, and fiber. Green, leafy, and yellow vegetables are preferred because of their low carbohydrate content.
"Trials to Address Efficacy of Midodrine 18 Years After It Gains FDA Approval" // I am really hoping that midodrine will be proven to be beneficial. It is a necessary treatment for many of us with low blood pressure. Removal of this drug from the market would be devastating.
What is the DASH Eating Plan? DASH refers to Dietary Approaches to Stop Hypertension (DASH) and is a flexible and balanced eating plan that has been shown to lower high blood pressure. The DASH eating plan was one of three eating plans that were compared in research studies sponsored by the National Heart, Lung, and Blood Institute (NHLBI).
It’s not because I’m terrified of germs. It’s because I’ve spent too many hours in the emergency room, too many nights in the hospital, too many days sitting in surgery waiting rooms, too many weekday afternoons administering immunoglobulin infusions, too many visits to the lab to get immunoglobulin levels drawn. I’m “that” mom because I’m looking at the world through the lens of PIDD.
Hashimoto's Thyroiditis (HT) in Patients With Normal Thyroid-stimulating Hormone Levels--HT is one of the most common autoimmune endocrine disorders and often leads to hypothyroidism. It has been shown to substantially affect a patient's quality of life. Associated diseases are thought to promote hypothyroidism. Patients often suffer symptoms when thyroid tests are in the normal range. Independent of thyroid function, HT is linked associated with many other autoimmune disorders.
Rheumatoid arthritis (RA) is a common, chronic polyarthritis which may be classified as a diffuse, multi-system, connective tissue disease. The hallmarks of RA are positive testing for immunoglobulin M (IgM) rheumatoid factor; bilateral, usually symmetrical joint disease; erosive changes noted radiographically; and persistent inflammatory synovitis.
Takeda agreed to fork over $8 million initially to Resolve as the startup works toward the start of first human studies in 2013 for the lead compound, RSLV-132, a nuclease Fc fusion protein. The deal includes backup compounds as well. And if planned Phase 1b/2a work for the front runner goes as hoped, Takeda could use its exclusive option from the deal and take over global development and commercialization of the compound, leading to up to $247 million in development payments to Resolve.
Department of Neurology at Miller School of Medicine #university #of #miami #miller #school #of #medicine http://usa.nef2.com/department-of-neurology-at-miller-school-of-medicine-university-of-miami-miller-school-of-medicine/ # exp:news_feed:department site=”neurology” category_id=”291″ parse=”inward” year=”” month=”” count=”3″ Monoclonal antibodies could be a whole new class of therapies to treat debilitating episodic or chronic cluster headaches. For this reason, researchers are actively…
B cell dependent EAE Sefia E Pryce G Meier UC Giovannoni G Baker D. Depletion of CD20 B cells fails to inhibit relapsing mouse experimental autoimmune encephalomyelitis. Mult Scler Relat Disord. 2017 May;14:46-50. doi: 10.1016/j.msard.2017.03.013. This paper warns about the value of using mice to understand B cell activity in MS. It looks at a few published studies or mouse studies and asks you to think. If we look in the abstract in the paper below the work is now done in a B cell- and…
The "M" Word - Thyroid Cancer Metastasized To Lungs
When is an Inhibitory Antibody not an Inhibitory Antibody? When its Neutralizing!! Free Grant Idea of the Month#ClinicSpeak #NewsSpeak To continue explaining our recent paper and the last bit for Detective Week so MD is back in his Civvies next week.David Baker; Samuel S. Herrod Cesar Alvarez-Gonzalez Gavin Giovannoni; Klaus SchmiererInterpreting Lymphocyte Reconstitution Data From the Pivotal Phase 3 Trials of Alemtuzumab.JAMA Neurol. Published online June 12 2017…